Clinical Trial Update: Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation [NA]

View source ↗

Summary

A clinical trial is recruiting to test an immunological reset approach using non-myeloablative autologous stem cell transplantation to enable HLA-compatible kid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplantation

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Kidney Disease, Kidney Transplant | NA | Status: RECRUITING